EHC Overview

Encompass Health Corporation is a provider of inpatient rehabilitation services. The Company provides specialized rehabilitative treatment, using technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability. It operates hospitals in approximately 39 states and Puerto Rico, with concentrations in Florida and Texas. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver patient care services. It offers neurological, spinal & brain-related rehabilitation, which include brain injury rehabilitation, multiple trauma rehabilitation, neurological rehabilitation, spasticity management, spinal cord injury rehabilitation and stroke rehabilitation. It also offers orthopedic & joint-related rehabilitation, which includes amputee rehabilitation, chronic condition management, hip rehabilitation and orthopedic rehabilitation.

Wall Street analysts forecast EHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EHC is146.75 USD with a low forecast of 134.00 USD and a high forecast of 160.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Encompass Health Corp revenue for the last quarter amounts to 1.59B USD, increased 9.01

Encompass Health Corp. EPS for the last quarter amounts to 1.93 USD, increased 30.41

Encompass Health Corp (EHC) has 24611 emplpoyees as of June 21 2026.

Today EHC has the market capitalization of 9.72B USD.